Skip to content

A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01918670
Acronym
FrenchAF
Enrollment
Unknown
Registered
2013-08-08
Start date
2010-11-30
Completion date
2013-12-31
Last updated
2013-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observation of Outcome After Catheter Ablation of Atrial Fibrillation

Keywords

atrial fibrillation; catheter ablation; relapse; stroke; death

Brief summary

Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients. We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.

Interventions

electric pulmonary vein disconnection

Sponsors

University Hospital, Grenoble
CollaboratorOTHER
Nouvelle Clinique Nantaise, Nantes, France
CollaboratorUNKNOWN
Hôpital Privé de Parly II - Le Chesnay
CollaboratorOTHER
Rennes University Hospital
CollaboratorOTHER
University Hospital, Rouen
CollaboratorOTHER
Clinique Pasteur
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter

Exclusion criteria

* patients undergoing catheter ablation of other types of arrhythmia

Design outcomes

Primary

MeasureTime frameDescription
Atrial fibrillation relapsestarting 3 months after the procedure till an average of 18months follow-upDocumentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure

Secondary

MeasureTime frameDescription
Early atrial fibrillation relapsefirst 3 monthsDocumented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026